Showing results (691-700 of 2,663) with videos related to

Sort By:
Pageof 267
Clinical & Experimental Ophthalmology|January 11, 2021
Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein IgG associated disorder: A comprehensive neuro-ophthalmic reviewJaya Sharma, M Tariq Bhatti, Helen V Danesh-Meyer
Clinical & Experimental Ophthalmology|January 13, 2021
Diabetic eye disease: A review of screening and management recommendationsMichael J Gale, Brittni A Scruggs, Christina J Flaxel
Clinical & Experimental Ophthalmology|June 17, 2017
Aqueous vascular endothelial growth factor and aflibercept concentrations after bimonthly intravitreal injections of aflibercept for age-related macular degenerationTomoko Sawada, Xiying Wang, Osamu Sawada, et al.
Clinical & Experimental Ophthalmology|June 10, 2017
Prevalence of trachomatous trichiasis in Australia: the National Eye Health SurveyMohamed Dirani, Stuart Keel, Joshua Foreman, et al.
Clinical & Experimental Ophthalmology|June 1, 2017
Can we improve the efficacy of modern cataract surgery by using different tip designs? A comparison of balanced and tapered tip in femtosecond laser-assisted cataract surgery and manual phacoemulsificationMilena Pahlitzsch, Marie-Luise Pahlitzsch, Uly Sumarni, et al.
Clinical & Experimental Ophthalmology|February 23, 2022
Driving behaviour and visual compensation in glaucoma patients: Evaluation on a driving simulatorJulien Adrian, Colas Authié, Johan Lebrun, et al.
Clinical & Experimental Ophthalmology|February 2, 2022
Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomesJavier Zarranz-Ventura, Alba Parrado-Carrillo, Vuong Nguyen, et al.
Clinical & Experimental Ophthalmology|July 23, 2022
One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusionNancy Wang, Adrian Hunt, Vuong Nguyen, et al.
Clinical & Experimental Ophthalmology|September 22, 2021
Intravitreous treatment of severe ocular von Hippel-Lindau disease using a combination of the VEGF inhibitor, ranibizumab and PDGF inhibitor, E10030: Results from a phase 1/2 clinical trialChristopher K Hwang, Emily Y Chew, Catherine A Cukras, et al.
Clinical & Experimental Ophthalmology|December 5, 2023
Unilateral intraindividual comparison and bilateral performance of a monofocal spherical and diffractive extended depth of field intraocular lens mix-and-match approachJascha A Wendelstein, Marina Casazza, Sophia Reifeltshammer, et al.
Pageof 267